Hi, what are you looking for?
Jewish Business News
Search results for " Teva Pharmaceutical"
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
StartUps
The Technion received approval for 65 patents in the U.S. in 2014, the most of any Israeli university.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
Deal to give Perrigo manufacturing technology for softgel products
Money
BioLight also announced that a new private investor participated in the private placement with the same terms in the amount of $350, 000.
Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Business
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Court
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
Business
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been...